|
End-of-day quote
Egyptian Exchange
2026-09-29
|
5-day change | 1st Jan Change | ||
| 1.480 EGP | +1.37% |
|
-11.90% | +29.82% |
| Market Cap | 5.06B 97.24M 85.82M 81.19M 73.64M 138M 9.33B 139M 974M 375M 4.76B 365M 357M 15.33B | P/E 2026 * |
24.7x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.98B 95.71M 84.46M 79.92M 72.48M 136M 9.18B 137M 959M 369M 4.69B 359M 352M 15.09B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.19x |
| Free-Float |
30.46% | Yield 2026 * |
2.03% | Yield 2027 * | 2.7% |
| 1 day | +1.37% | ||
| 1 week | -11.90% | ||
| Current month | -1.33% | ||
| 1 month | -1.33% | ||
| 3 months | +24.37% | ||
| 6 months | +10.45% | ||
| Current year | +29.82% |
| 1 week | 1.41 |  | 1.64 |
| 1 month | 1.41 | | 1.81 |
| Current year | 1.02 | | 1.81 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
Tamir Saeed
BRD | Director/Board Member | - | 2020-12-31 |
Norbert Lurz
BRD | Director/Board Member | - | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.37% | -11.90% | -49.49% | -43.30% | 95.87M | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.03% | -0.84% | +21.00% | +40.45% | 364.3B | |
| Weighted average by Cap. | -0.05% | +0.42% | +38.91% | +70.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 22.85M 20.17M 19.08M 17.31M 32.44M 2.19B 32.77M 229M 88.23M 1.12B 85.82M 83.95M 3.6B | 1.55B 29.81M 26.3M 24.89M 22.57M 42.31M 2.86B 42.73M 299M 115M 1.46B 112M 109M 4.7B |
| Net income | 206M 3.96M 3.49M 3.3M 3M 5.62M 380M 5.67M 39.63M 15.27M 194M 14.86M 14.53M 624M | 283M 5.43M 4.8M 4.54M 4.12M 7.72M 522M 7.79M 54.44M 20.98M 266M 20.41M 19.96M 857M |
| Net Debt | -79.7M -1.53M -1.35M -1.28M -1.16M -2.17M -147M -2.19M -15.33M -5.91M -75M -5.75M -5.62M -241M | -110M -2.11M -1.86M -1.76M -1.6M -3M -203M -3.03M -21.16M -8.16M -104M -7.93M -7.76M -333M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | EGP 1.480 | +1.37% | 35,503,983 |
| 26-09-28 | EGP 1.460 | -2.01% | 30,443,066 |
| 26-09-27 | EGP 1.490 | -6.29% | 25,427,091 |
| 26-09-24 | EGP 1.590 | -2.45% | 38,671,818 |
| 26-09-23 | EGP 1.630 | -2.98% | 23,193,515 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.480EGP
Average target price
1.570EGP
Spread / Average Target
+6.08%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
